WO2004081568A1 - 検体の検査方法及びその検査方法に用いる検体収容用容器 - Google Patents
検体の検査方法及びその検査方法に用いる検体収容用容器 Download PDFInfo
- Publication number
- WO2004081568A1 WO2004081568A1 PCT/JP2004/003025 JP2004003025W WO2004081568A1 WO 2004081568 A1 WO2004081568 A1 WO 2004081568A1 JP 2004003025 W JP2004003025 W JP 2004003025W WO 2004081568 A1 WO2004081568 A1 WO 2004081568A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- labeled antibody
- container
- test
- cap
- filter
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5082—Test tubes per se
- B01L3/50825—Closing or opening means, corks, bungs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
- G01N33/5304—Reaction vessels, e.g. agglutination plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0681—Filter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
Definitions
- the present invention relates to a method for testing a sample and a container for storing a sample used for the test method.
- the present invention relates to a method for detecting the presence or absence of a target in a sample in an immunological detection method using an antigen-antibody reaction, and a sample storage container used for the test method. More specifically, the present invention relates to a novel test method capable of easily and quickly testing for the presence or absence of a target in a sample in a test method utilizing an immune reaction by an antigen-antibody, and a new sample container used for the test method.
- the general method is a labeled antibody solution in which a sample such as blood, urine, sputum, saliva, nasal discharge or a diluted sample solution is labeled with an antibody, a color-identifying substance such as an enzyme, a precious metal colloid, a colored latex, or a dye.
- a sample such as blood, urine, sputum, saliva, nasal discharge or a diluted sample solution
- a color-identifying substance such as an enzyme, a precious metal colloid, a colored latex, or a dye.
- the amount of the immune complex is measured visually or as an optical change, and the amount of the antigen in the sample is determined. Qualitative or quantitative measurements are performed.
- a simple diagnostic kit based on ELISA enzyme-linked immunosorbent assay has been developed and is commercially available.
- Japanese Patent Application Laid-Open Publication No. 2000-12012-7575 and Japanese Patent Application Laid-Open Publication No. 2000-230931 disclose examples of these.
- type A Since the emergence of drugs that are effective against influenza virus B and influenza virus B, reagents and instruments that can distinguish and measure types A and B have been developed.
- a typical example of how to use a kit for a simple firewood diagnosis of influenza infection using a colloidal gold-labeled antibody solution is as follows.
- test device filled with a carrier (porous membrane material such as membrane) on which anti-influenza antibody is immobilized and an absorbent material (such as absorbent cotton or absorbent paper) with the entire amount of the mixture in the second tubular container.
- a carrier porous membrane material such as membrane
- an absorbent material such as absorbent cotton or absorbent paper
- influenza virus and the type of influenza virus are differentiated and diagnosed.
- the above-mentioned conventional kit for simple diagnosis of influenza infection is a simple test instrument, but there are some points that need to be improved.
- the examiner in order to react the diluted sample solution with the colloidal gold-labeled antibody, the examiner needs to drop the colloidal gold-labeled antibody solution onto the diluted sample solution as described above, and then from the first container to the second container. A complicated operation such as transfer is required.
- the drop volume of the colloidal gold-labeled antibody solution tends to fluctuate due to individual differences among the There is difficulty in sex.
- the colloidal gold-labeled antibody solution tends to aggregate alone depending on the temperature, and may not pass through the cap with filter.
- the colloidal gold-labeled antibody is washed and filtered on the test device during inspection.
- the drop amount greatly differs. If the amount of the labeled antibody solution is small, the sensitivity will be insufficient and sufficient reaction will not occur, and if the amount is large, the probability of nonspecific reaction will increase. Errors tend to occur. In addition, if the labeled antibody is stored in a liquid state for a long period of time, accurate measurement may be difficult.
- the present invention solves all of the problems of these conventional inspection methods and inspection instruments.
- the present invention provides an immunological test method using an antigen-antibody reaction, which reduces the influence of individual differences among examiners, prevents the occurrence of nonspecific reactions, and provides a diagnostic result.
- the first object is to provide a container for accommodating a specimen for use in the test method.
- the present invention provides a method for testing for the presence or absence of influenza virus infection, which reduces the effects of individual differences among testers, prevents the occurrence of nonspecific reactions, and provides reproducibility of diagnostic results and storage of reagents.
- a second object is to provide a highly stable test method and to provide a container for accommodating a specimen used in the test method.
- the present invention furthermore simplifies the use of a simple diagnostic kit to which an immunological test method is applied, reduces the influence of individual differences among examiners, and prevents the occurrence of nonspecific reactions.
- a third object is to provide a test method that is rich in reproducibility of diagnostic results and storage stability of reagents, and to provide a container for accommodating a specimen used in the test method.
- the invention according to claim 1 is a method for immunologically detecting a sample, comprising: a step of diluting a cap containing a filter impregnated with a labeled antibody; A sample test method characterized by being mounted on a container body containing a liquid, injecting a diluted sample solution from the container into a test device, observing the reaction, and testing for the presence of an object in the sample. .
- the invention according to claim 2 of the present invention is the detection method according to claim 1, wherein the labeled antibody is a gold colloid-labeled antibody.
- the invention according to claim 3 of the present invention is the test method according to claim 1 or 2, wherein the target substance in the sample is an influenza virus.
- the invention described in claim 4 of the present invention is the test method according to any one of claims 1 to 3, which is used as a method for reacting a sample with a labeled antibody in a simple diagnostic kit.
- a cap containing a filter impregnated with a labeled antibody is attached to a container body for containing a diluted sample solution, and
- the invention according to claim 6 of the present invention is the sample storage container according to claim 5, wherein the labeled antibody is a colloidal gold-labeled antibody. Container.
- the object in the sample 7 of the present invention the object in the sample 7.
- the invention according to claim 8 of the present invention is the sample-housing container according to any one of claims 5 to 7, which is used as a component of a simple diagnostic kit.
- FIG. 1 is a schematic view of an example of a sample test method and a sample container used in the test method according to the present invention.
- reference numeral 1 denotes a container main body of a sample storage container, 11 denotes a diluted sample liquid, and 12 denotes a mouth end of the container main body.
- 1A indicates an influenza A virus antigen
- 1B indicates an influenza B virus antigen.
- 2 is a cap
- 21 is a filter impregnated with colloidal gold-labeled antibody
- 22 and 23 are other filters
- 24 is a cap fitting
- 25 is a cap nozzle
- 3 is a cap nozzle.
- 1 shows a container for accommodating a specimen in which a cap is attached to a container body.
- 4 indicates a test device, 41 indicates an opening thereof, and 42 indicates a surface thereof.
- the labeled antibody is used as a method of contacting a sample with a labeled antibody.
- Make an impregnated filter put the filter in the cap, attach the cap to the container body containing the diluted sample liquid, and inject the diluted sample liquid into the test device through the cap filter.
- the method employs a method in which an analyte in the liquid is brought into contact with a labeled antibody impregnated in a filter to form an immune complex.
- a member generally used as a filter cloth or filter paper such as a high-density polyethylene polymer filter cloth, a glass fiber filter paper, or a cellulose filter paper, may be used.
- the cap is a cap that can be attached to a container filled with at least a diluted sample liquid or the like, and has a structure that allows a liquid to pass therethrough and a structure that can incorporate a filter.
- the desired shape of the cap can be selected, such as a conical shape, a disk shape, a combination of a cylindrical shape and a conical shape.
- the method of impregnating the filter with the labeled antibody includes a filter Any method such as immersing one member (filter cloth or filter paper) in the labeled antibody solution or applying or dropping the labeled antibody solution on the member can be adopted.
- a fixed amount may be applied using an applicator.
- An example of how to make a filter impregnated with a labeled antibody is shown below.An appropriate filter cloth or filter paper cut out according to the shape and size of the inside of the cap to be attached to the container body containing the diluted sample liquid is labeled antibody. After dripping the solution sufficiently and impregnating it, dry it at 35 ° C to 38 ° C for about 30 to 40 minutes to produce it. Natural drying at room temperature is acceptable.
- any method of incorporating the filter impregnated with the labeled antibody into the cap is optional.
- a filter made of glass fiber filter paper impregnated with the labeled antibody, or another filter from the nozzle side (discharge port side) of the cap A combination of a filter impregnated with a labeled antibody and another filter, such as a filter made of glass fiber filter paper and a filter made of high-density polyethylene polymer filter cloth, can be loaded in a multilayer structure.
- any substance such as an enzyme, a noble metal colloid, a dye, or a colored latex may be used, but it is preferable to use noble metal colloid particles. It is preferable to use colloidal gold particles prepared by a widely known colloidal gold preparation method.
- FIG. 1 is a schematic diagram for explaining, as an example of the present invention, a method for detecting an influenza virus and a container for accommodating a diluted sample liquid used in the method for detecting the influenza virus.
- reference numeral 1 denotes a plastic container main body containing a diluted sample liquid 11, which has a test tube shape.
- the diluted sample solution 11 is a buffer solution obtained from a patient's nasal fluid containing influenza type A virus antigen 1A (shown by diamonds in the figure) and influenza B virus antigen 1B (shown by squares in the figure). It is manufactured by adding a surfactant and the like.
- reference numeral 2 denotes a plastic cap having a fitting portion 24 that fits with the mouth end portion 12 of the container body 1 and a nozzle portion 25.
- the body portion of the cap 2 has a portion closer to the nozzle portion 25.
- the filter paper made of glass fiber was impregnated with colloidal gold-labeled antibody.
- Reference numeral 4 denotes a plastic test device having an opening 41 on the surface.
- the test device contains, from the bottom side, absorbent cotton, absorbent paper, and a membrane on which influenza virus A and B antibodies are immobilized.
- the diluted sample liquid 11 is allowed to stand in the sample container 3 for about 5 minutes, the whole amount is dropped from the nozzle 25 of the cap 2 to the opening 41 of the test device 4.
- the membrane is washed with a washing solution, and the state of spots appearing in the opening 41 is inspected by visual observation to diagnose the presence or absence of infection with influenza virus.
- an opening [41] is provided on the surface for adding a diluted sample solution.
- a plastic case [42] absorbent cotton, cotton absorbent paper, and antibody-immobilized membrane are stacked in this order from the bottom, and the three types of fixed antibodies are stored so that they are located near the center of the opening.
- a test device [4] was manufactured.
- FIG. 1 A, R, and B shown in test device [4] indicate the mouse anti-influenza A virus antibody, anti-mouse IgG antibody, and mouse anti-imbleenza B virus antibody, respectively. The part immobilized in the figure is shown.
- an aqueous solution of tetrachlorite ( ⁇ ) acid and an aqueous solution of trisodium citrate were added and heated with stirring. Then, it was cooled in ice water to produce gold colloid.
- the particle size of the gold colloid was approximately 60 nm.
- the obtained gold colloid and a mouse anti-influenza A type virus antibody and a mouse anti-influenza A type B virus antibody were added to a borate buffer (p H 9.0) and stirred at room temperature for labeling. The mixture was further blocked by adding a 10% aqueous BSA solution, and then precipitated by centrifugation to obtain two types of colloidal gold-labeled antibodies.
- colloidal gold-labeled antibodies Two types were suspended together in PBS containing 0.2% T-ween 20%, 1.0% sucrose and 0.2% BSA, and labeled with colloidal gold for influenza A virus.
- Glass fiber filter paper F 075-14 was selected from the members shown in Table 1, and disk-shaped sections (7.5 mm in diameter) were cut out according to the shape and dimensions of the inside of the cap. To each of the disc-shaped sections, 60 ⁇ L of a colloidal gold-labeled antibody solution was dropped and air-dried to prepare a filter [21] impregnated with a colloidal gold-labeled antibody.
- cap of the present invention a filter made of high-density polyethylene polymer filter cloth [23], glass fiber [22], which consists of a series of filter papers
- a filter [21] impregnated with a colloidal gold-labeled antibody is placed on top of the cap [2], and a filter incorporating a filter impregnated with a colloidal gold-labeled antibody (hereinafter referred to as "cap of the present invention").
- cap of the present invention was used by being attached to a container body [1] containing a diluted sample liquid [11].
- the diluted sample solution containing the purified antigen of Influenza (type A virus: derived from Kitakyu syu / 1 59/93 strain, type B virus: derived from Lee / 40 strain) was prepared by converting each virus into TC I Dso / It was prepared by adding it to the diluent so that the test unit was 2 ⁇ 10 6 to 1 ⁇ 10 5 .
- the diluted sample solution containing the nasal secretion sample was prepared by placing the cotton body from which the nasal secretion was collected in a container containing 1.2 mL of the diluted sample solution and eluting the nasal secretion component into the diluted sample solution.
- the container [1] containing 1.2 mL of the diluted sample solution containing the purified influenza antigen or nasal sample prepared in the step (a) or the step (a) above was charged with the cap [2] of the present invention. It was attached and the whole amount was dropped into the opening [41] of the test device [4].
- the cap of the present invention was prepared according to the method of Example 1.
- the cap of the present invention was attached to a container body containing 1.2 mL of a diluted sample solution containing neither an influenza purified antigen nor a nasal discharge sample, and the whole amount was dropped into a test tube.
- the amount of gold colloid-labeled antibody in the filtrate was calculated from the absorbance at 537 nm of the obtained filtrate, and the recovery was determined by comparing the amount with the amount of the impregnated gold colloid-labeled antibody. Table 1 shows the test results.
- Table 1 shows the test results.
- the recovery rate of the gold colloid-labeled antibody was used as a reference.
- a member filter cloth or filter paper that can be used for producing a filter impregnated with the labeled antibody. found.
- the cap of the present invention was prepared using LG 20 as a member of a filter, and was placed in a container body containing 1.2 mL of a diluted sample solution containing purified influenza antigens (types A and B) at the concentrations shown in Table 2.
- the test was carried out according to the method of Example 1 with mounting.
- a filter impregnated with the labeled antibody incorporated in the cap of the present invention was used.
- the test was carried out with the cap replaced with a filter not impregnated with the labeled antibody. Table 2 shows the test results.
- the cap of the present invention was produced using LG20 as a member of a filtration filter and changing the amount of the gold colloid-labeled antibody solution to be impregnated as shown in Table 3.
- a diluted sample solution containing a nasal sample (negative sample) for which influenza A and influenza B viruses have been confirmed to be absent by the PCR method 1.2 Container containing 2 mL The test was performed according to the method of Example 1 with the cap of the present invention attached to the main body.
- As a control method one to three drops of colloidal gold-labeled antibody solution were further dropped into the container body containing the diluted sample solution containing purified influenza antigen using a dropper bottle, and then the labeled antibody incorporated in the cap of the present invention was impregnated.
- the test was carried out with the cap replaced with a filter that had not been impregnated with the labeled antibody. Table 3 shows the test results.
- a cap of the present invention was prepared according to Example 1 using LG 20 as a filter member, and stored at 30 ° C. (30% humidity) and 37 ° C. (30% humidity).
- the cap contains the influenza purified antigen (type A virus: derived from Kitakyusyu / 159/93 strain, type B virus: derived from Lee 40 strain) at the 0th, 6th, and 9th month of the start of storage.
- Diluted Sample Solution (Diluted Sample Solution Containing 2 ⁇ 10 6 in Each Virus TC I Dso / test Unit) 1.
- the test was carried out according to the method of Example 1 by attaching to a container body containing 2 mL.
- a cap of the present invention was prepared according to the method of Example 1 using LG 20 as a filter member.
- the drop bottle containing the cap of the present invention and the colloidal gold-labeled antibody solution was placed in an airtight container together with a desiccant, and stored at ⁇ 30 ° C. for 24 hours.
- the cap of the present invention can be used as a diluted sample solution containing a nasal sample (negative sample) or an influenza purified antigen (influenza purified antigen) in which it has been confirmed by PCR that the influenza A virus and the influenza B virus are not present.
- Example 1 a viruses: K itakyusyu / 159 / from 93 strain, B-type virus: L ee, 40 from the strain, the respective virus containing 2 X 10 6 in TC ID 5 .Z test units) diluted specimen solution 1. 2 m
- the test was carried out in accordance with the method of Example 1 by attaching to a container containing L.
- As a control method two drops of the colloidal gold-labeled antibody solution returned to room temperature were dropped into the container body containing the negative sample or the diluted sample solution containing purified influenza antigen.
- the test was performed by attaching a cap in which the filter impregnated with the labeled antibody contained in the cap of the invention was replaced with a filter not impregnated with the labeled antibody.
- the test was performed by the same operation as the control method, except that the colloidal gold-labeled antibody solution stored at room temperature was used instead of the colloidal gold-labeled antibody solution stored at 130 ° C. Table 5 shows the test results.
- the method of the present invention was applied when a mixture of the gold colloid-labeled antibody solution and the diluted sample solution was dropped into the opening of the test device.
- the filter in which the labeled antibody impregnated in the cap was impregnated and replaced with a filter not impregnated with the label antibody was colored red, confirming that the gold-labeled antibody was captured by the filter.
- the control method while the coloration of the R part, which should originally be colored "ten", is "+", the coloration "+” is confirmed even in the negative sample, which should not be observed.
- Test Examples 4 and 5 revealed that the cap of the present invention is excellent in storage stability of the labeled antibody, so that it is not necessary to strictly control the temperature during transportation and the like.
- the cap containing the filter impregnated with the labeled antibody is attached to the container body containing the diluted sample solution, and the diluted sample solution is removed from the container. Since the reaction is observed by injecting it into the test device, there is no need to add the labeled antibody solution to the diluted sample solution as in the conventional test method.In addition, the diluted sample solution is transferred from the first container to the second container. There is no need to frog. In other words, it became a very simple inspection method. In addition, since it is not necessary to drop the labeled antibody solution on the diluted sample solution, it is possible to prevent an error caused by the amount of the labeled antibody solution dropped.
- the container for storing a sample according to the present invention has a very simple structure since a container for storing a diluted sample liquid is provided with a cap having a built-in filter impregnated with a labeled antibody.
- it is easy to use and the test accuracy is not influenced by the examiner it is most suitable for use as a component of a simple diagnostic kit for a sample using an immune reaction.
- the method for testing a sample according to the present invention and the device for storing a sample used in the test method can be used for testing and diagnosing various symptoms such as the presence or absence of virus infection such as influenza virus and the determination of pregnancy.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Clinical Laboratory Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004219769A AU2004219769A1 (en) | 2003-03-10 | 2004-03-09 | Method of examining specimen and specimen container to be used in the examinaton method |
DE602004029990T DE602004029990D1 (de) | 2003-03-10 | 2004-03-09 | Verfahren zur untersuchung von proben und probenbehälter zur verwendung bei dem untersuchungsverfahren |
CN200480006372.XA CN1759318B (zh) | 2003-03-10 | 2004-03-09 | 检测样品的方法和用于检测方法中的样品容器 |
EP04718761A EP1602927B1 (en) | 2003-03-10 | 2004-03-09 | Method of examining specimen and specimen container to be used in the examination method |
AT04718761T ATE487941T1 (de) | 2003-03-10 | 2004-03-09 | Verfahren zur untersuchung von proben und probenbehälter zur verwendung bei dem untersuchungsverfahren |
JP2005503524A JP4229943B2 (ja) | 2003-03-10 | 2004-03-09 | 検体の検査方法及びその検査方法に用いる検体収容用容器 |
US10/546,691 US7442498B2 (en) | 2003-03-10 | 2004-03-09 | Method of examining specimen and specimen container to be used in the examination method |
NO20054629A NO20054629D0 (no) | 2003-03-10 | 2005-10-07 | Fremgangsmate for undersokelse av prover, samt provebeholder som skal anvendes i undersokelsesfremgangsmaten |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003063832 | 2003-03-10 | ||
JP2003-063832 | 2003-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004081568A1 true WO2004081568A1 (ja) | 2004-09-23 |
Family
ID=32984446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/003025 WO2004081568A1 (ja) | 2003-03-10 | 2004-03-09 | 検体の検査方法及びその検査方法に用いる検体収容用容器 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7442498B2 (ja) |
EP (1) | EP1602927B1 (ja) |
JP (1) | JP4229943B2 (ja) |
CN (1) | CN1759318B (ja) |
AT (1) | ATE487941T1 (ja) |
AU (1) | AU2004219769A1 (ja) |
DE (1) | DE602004029990D1 (ja) |
NO (1) | NO20054629D0 (ja) |
WO (1) | WO2004081568A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011095599A1 (en) | 2010-02-05 | 2011-08-11 | Copan Italia S.P.A. | Test kit |
JP2015148629A (ja) * | 2008-04-09 | 2015-08-20 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | 被覆ナノ粒子を使用した高感度免疫学的検定 |
WO2022107876A1 (ja) * | 2020-11-20 | 2022-05-27 | 株式会社堀場製作所 | 捕捉用デバイス |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010122392A1 (en) * | 2009-04-21 | 2010-10-28 | Span Diagnostics Ltd. | Single-step sample processing device |
JP5831448B2 (ja) * | 2010-04-14 | 2015-12-09 | 日東紡績株式会社 | 試料中の分析対象物質を測定するための検査器具及びそれを用いた分析対象物質の測定方法 |
JP6820865B2 (ja) | 2015-04-29 | 2021-01-27 | ペルキネルマー ヘルス サイエンシーズ, インコーポレイテッド | 試料収集および送達装置 |
US20180348215A1 (en) * | 2017-05-31 | 2018-12-06 | Waters Technologies Corporation | Systems and methods for measuring a concentration of an analyte |
CN110632297A (zh) * | 2018-10-11 | 2019-12-31 | 东莞东阳光医疗智能器件研发有限公司 | 一种免疫检测试剂盒及其测定方法和制备方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0468672A1 (en) | 1990-07-18 | 1992-01-29 | La Mina Ltd. | Urine testing module with cytology cup |
WO1992018844A1 (en) | 1991-04-18 | 1992-10-29 | La Mina Ltd. | Liquid specimen container and attachable testing modules |
EP0582231A1 (en) | 1992-08-03 | 1994-02-09 | Becton, Dickinson and Company | Solid phase assay |
EP0617284A2 (en) | 1993-03-18 | 1994-09-28 | Mochida Pharmaceutical Co., Ltd. | Apparatus and process for simplified measurement |
JPH07260777A (ja) | 1994-03-18 | 1995-10-13 | Nissho Corp | 検体採取器具 |
EP0687910A1 (en) | 1994-06-15 | 1995-12-20 | Johnson & Johnson Clinical Diagnostics, Inc. | Test kit and method for competitive specific binding assay |
JPH0882622A (ja) | 1994-09-13 | 1996-03-26 | Sekisui Chem Co Ltd | 便潜血判定装置 |
JP2000230931A (ja) | 1998-12-07 | 2000-08-22 | Katakura Industries Co Ltd | 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット |
WO2000072012A2 (en) | 1999-05-24 | 2000-11-30 | Abbott Laboratories | Apparatus for pretreating a sample containing an analyte |
EP1081496A1 (en) | 1999-08-31 | 2001-03-07 | Becton, Dickinson and Company | Flow-through assay for visually detecting the presence of influenza A and B |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL78854A (en) | 1985-05-31 | 1991-11-21 | Murex Corp | Biological fluid diagnostic device |
US4874691A (en) | 1987-10-16 | 1989-10-17 | Quadra Logic Technologies Inc. | Membrane-supported immunoassays |
CN2113490U (zh) * | 1992-03-24 | 1992-08-19 | 祝加贝 | 新型膜式渗滤一检多项测试药盒 |
CN2230037Y (zh) * | 1995-04-06 | 1996-06-26 | 王继华 | 固态胶体金免疫检测试剂盒 |
-
2004
- 2004-03-09 JP JP2005503524A patent/JP4229943B2/ja not_active Expired - Lifetime
- 2004-03-09 US US10/546,691 patent/US7442498B2/en not_active Expired - Lifetime
- 2004-03-09 DE DE602004029990T patent/DE602004029990D1/de not_active Expired - Lifetime
- 2004-03-09 AU AU2004219769A patent/AU2004219769A1/en not_active Abandoned
- 2004-03-09 WO PCT/JP2004/003025 patent/WO2004081568A1/ja active Application Filing
- 2004-03-09 AT AT04718761T patent/ATE487941T1/de not_active IP Right Cessation
- 2004-03-09 EP EP04718761A patent/EP1602927B1/en not_active Expired - Lifetime
- 2004-03-09 CN CN200480006372.XA patent/CN1759318B/zh not_active Expired - Fee Related
-
2005
- 2005-10-07 NO NO20054629A patent/NO20054629D0/no not_active Application Discontinuation
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0468672A1 (en) | 1990-07-18 | 1992-01-29 | La Mina Ltd. | Urine testing module with cytology cup |
JPH06308126A (ja) * | 1990-07-18 | 1994-11-04 | La Mina Ltd | 生物学的流体における分子試験体を試験し、細胞成分を収集する装置および方法 |
WO1992018844A1 (en) | 1991-04-18 | 1992-10-29 | La Mina Ltd. | Liquid specimen container and attachable testing modules |
JPH06167497A (ja) * | 1992-08-03 | 1994-06-14 | Becton Dickinson & Co | 固相アッセイ |
EP0582231A1 (en) | 1992-08-03 | 1994-02-09 | Becton, Dickinson and Company | Solid phase assay |
EP0617284A2 (en) | 1993-03-18 | 1994-09-28 | Mochida Pharmaceutical Co., Ltd. | Apparatus and process for simplified measurement |
JPH06273419A (ja) * | 1993-03-18 | 1994-09-30 | Mochida Pharmaceut Co Ltd | 簡易測定装置および方法 |
JPH07260777A (ja) | 1994-03-18 | 1995-10-13 | Nissho Corp | 検体採取器具 |
EP0687910A1 (en) | 1994-06-15 | 1995-12-20 | Johnson & Johnson Clinical Diagnostics, Inc. | Test kit and method for competitive specific binding assay |
JPH0882622A (ja) | 1994-09-13 | 1996-03-26 | Sekisui Chem Co Ltd | 便潜血判定装置 |
JP2000230931A (ja) | 1998-12-07 | 2000-08-22 | Katakura Industries Co Ltd | 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット |
WO2000072012A2 (en) | 1999-05-24 | 2000-11-30 | Abbott Laboratories | Apparatus for pretreating a sample containing an analyte |
JP2003500651A (ja) * | 1999-05-24 | 2003-01-07 | アボット・ラボラトリーズ | アナライト含有試料の作成方法 |
EP1081496A1 (en) | 1999-08-31 | 2001-03-07 | Becton, Dickinson and Company | Flow-through assay for visually detecting the presence of influenza A and B |
JP2001124775A (ja) | 1999-08-31 | 2001-05-11 | Becton Dickinson & Co | インフルエンザa型およびb型の存在を視覚的に検出するためのフロースルーアッセイ |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015148629A (ja) * | 2008-04-09 | 2015-08-20 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | 被覆ナノ粒子を使用した高感度免疫学的検定 |
WO2011095599A1 (en) | 2010-02-05 | 2011-08-11 | Copan Italia S.P.A. | Test kit |
JP2012037501A (ja) * | 2010-02-05 | 2012-02-23 | Shin Corporation:Kk | 検査用キット |
WO2022107876A1 (ja) * | 2020-11-20 | 2022-05-27 | 株式会社堀場製作所 | 捕捉用デバイス |
Also Published As
Publication number | Publication date |
---|---|
NO20054629L (no) | 2005-10-07 |
CN1759318A (zh) | 2006-04-12 |
JP4229943B2 (ja) | 2009-02-25 |
NO20054629D0 (no) | 2005-10-07 |
ATE487941T1 (de) | 2010-11-15 |
AU2004219769A1 (en) | 2004-09-23 |
DE602004029990D1 (de) | 2010-12-23 |
CN1759318B (zh) | 2013-12-18 |
EP1602927A4 (en) | 2007-08-15 |
US7442498B2 (en) | 2008-10-28 |
EP1602927A1 (en) | 2005-12-07 |
US20070015140A1 (en) | 2007-01-18 |
JPWO2004081568A1 (ja) | 2006-06-15 |
EP1602927B1 (en) | 2010-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3299271B2 (ja) | 毛細管血液抗原試験装置 | |
KR920009420B1 (ko) | 고체상 분석장치 및 이를 이용하는 방법 | |
JP4551660B2 (ja) | 診断検査方法 | |
JP3358737B2 (ja) | 改良された投与量応答曲線を有するアッセイ | |
JPH01229969A (ja) | 改良されたメンブレン支持形式の免疫分析法 | |
KR0163791B1 (ko) | 신속한 1회 수동분석을 실시하기 위한 장치 | |
JPH0588785B2 (ja) | ||
JPH01502526A (ja) | 必要物が完備したイムノアツセイ要素 | |
JPS62501447A (ja) | 生化学アツセイを実施するための方法、装置及びシステム | |
JP2007526993A (ja) | 粒子凝集検出方法および装置 | |
JP2007139556A (ja) | 新規な分析方法およびキット | |
KR101854240B1 (ko) | 후크 효과가 없는 면역크로마토그래피 스트립 센서 | |
WO2004081568A1 (ja) | 検体の検査方法及びその検査方法に用いる検体収容用容器 | |
US8632981B2 (en) | Method for a rapid test | |
US20140011190A1 (en) | Method for performing a rapid test | |
EP1933148B1 (en) | Urinary immunochromatographic multiparameter detection cup | |
JP3581360B2 (ja) | 抗体または抗原を用いた病態解析チップおよびその利用法 | |
JP3713178B2 (ja) | 梅毒抗体検出用免疫分析装置 | |
JPH03233360A (ja) | マルチウエルテスト | |
KR102602009B1 (ko) | 현장진단 멤브레인 진단 센서 | |
JPH08220099A (ja) | 物質の検出試薬及び慢性関節リウマチの検知法 | |
JPWO2003044534A1 (ja) | 微量検体中の分析対象物を測定するための免疫クロマトグラフィーテストストリップ | |
CN101175996A (zh) | 半定量免疫色谱装置 | |
JPH0933526A (ja) | 免疫学的検査キット | |
JPH0238972A (ja) | 免疫学的測定機器及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005503524 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004718761 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004219769 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004806372X Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2004219769 Country of ref document: AU Date of ref document: 20040309 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004219769 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004718761 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007015140 Country of ref document: US Ref document number: 10546691 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10546691 Country of ref document: US |